AI assistant
Sending…
Mersana Therapeutics, Inc. — Director's Dealing 2021
Aug 18, 2021
34702_dirs_2021-08-18_8d564d5e-8389-490e-85cb-02f6fc09ca0d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Mersana Therapeutics, Inc. (MRSN)
CIK: 0001442836
Period of Report: 2021-08-16
Reporting Person: MISRA TUSHAR (Chief Manufacturing Officer)
More from Mersana Therapeutics, Inc.
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Jan 30
Major Shareholding Notification
2026
Jan 9
Major Shareholding Notification
2026
Jan 8
Director's Dealing
2026
Jan 7
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6